Back to top

Guardant Health resumed with an Outperform at Bernstein

Bernstein resumed coverage of Guardant Health (GH) with an Outperform rating and $175 price target following a return from maternity leave. “Many t...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Guardant Health, Inc. (GH)